Observations in the Potential Role of Transforming Growth Factor-? in Cutaneous Fibrosis: Systemic Sclerosis
- 1 June 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 593 (1 Transfor), 161-171
- https://doi.org/10.1111/j.1749-6632.1990.tb16108.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989
- Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissuesArthritis & Rheumatism, 1988
- Cutaneous hypoxia in patients with systemic sclerosis (scleroderma)Archives of Dermatology, 1988
- Transforming Growth Factor-Beta: Selective Increase in Glycosaminoglycan Synthesis by Cultures of Fibroblasts From Patients With Progressive Systemic SclerosisJournal of Investigative Dermatology, 1987
- [17] Identification of receptor for type-β transforming growth factorMethods in Enzymology, 1987
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proceedings of the National Academy of Sciences, 1986
- D-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1982
- Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.Proceedings of the National Academy of Sciences, 1982
- Fibroblast selection in sclerodermaArthritis & Rheumatism, 1982
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980